rayner.com

Rayner

Rayner's email is iol_enquiries@rayner.com and Rayner's phone number is 4401903258900 .

Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention. With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. We are focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety. Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as o...

read more

Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention. With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. We are focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety. Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as our toric and multifocal IOL families are now complemented by the RayOne fully preloaded monofocal IOL injection system. Supplementary IOLs Designed to be implanted in the ciliary sulcus, Rayner Sulcoflex Pseudophakic Supplementary IOLs are available as aspheric, toric, multifocal and multifocal lenses, and offer a reversible solution for correcting residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag. OVDs Our Ophteis range offers a full spectrum of OVDs from dispersive to cohesive, enabling surgeons to select the OVD best suited to each specific cataract procedure. Ophteis FR Pro with sorbitol -- designed to deliver a new level of corneal endothelial protection from phaco induced trauma -- is the flagship product of Rayner’s ‘Ophteis’ OVD suite. Pharmaceuticals Although the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result. For that reason, Rayner recently acquired the business of Moorfields Pharmaceuticals. The acquisition will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient. Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries with direct markets in UK, Germany & Austria, the United States of America, Italy and Spain. We have the world’s longest commercial history of IOL design and manufacturing and have worked with cataract surgeons for longer than anyone else. In 2016, Rayner transferred its global headquarters to a brand new state of the art manufacturing plant, which has dramatically increased the company’s production capacity.

show less

View Top Employees for Rayner
img Website rayner.com
img Industry Medical Devices
img Location Worthing, West Sussex, United Kingdom
img Employees 170
img Founded 1910
img HQ The Ridley Innovation Centre 10 Dominion Way, Worthing
img Phone 440190-325-8900
img Email iol_enquiries@rayner.com
img Funding 0
img Competitors Medtronic, Stryker, Fresenius Medical Care, Boston Scientific, Bd, Baxter International ...,
img Website rayner.com
img Industry Medical Devices
img Location Worthing, West Sussex, United Kingdom
img Employees 170
img Founded 1910
img LinkedIn linkedin.com/company/rayner-iol
img HQ The Ridley Innovation Centre 10 Dominion Way, Worthing
img Phone 440190-325-8900
img Email iol_enquiries@rayner.com
img Funding 0

Top Rayner Employees